High-dose antipsychotic medication in maximum security

Journal of Forensic Psychiatry

Volumn 11, Issue 1, 2000, Pages 36-48

  Tavernor, Ros ^a   Swinton, Mark ^a   Tavernor, Simon ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Aggression; High dose antipsychotic; Psychosis; Treatment resistance

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PROCYCLIDINE;

ADULT; AGGRESSION; ARTICLE; BLOOD DYSCRASIA; CONTROLLED STUDY; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HOSPITAL; MORBIDITY; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; SIDE EFFECT; UNITED KINGDOM;

EID: 0034074530     PISSN: 09585184     EISSN: None     Source Type: Journal    
DOI: 10.1080/095851800362346     Document Type: Article

References (30)

1. Bazire, S. (1995) Psychotropic Drug Directory. Dinton: Mark Allen Publishing, pp. 72-3.
2. British National Formulary (1995) London: BMA and Royal Pharmaceutical Society of Great Britain, Pharmaceutical Press.
3. Brotman, A. W. and McCormick, S., III (1990) 'A Role for High Dose Antipsychotics'. J. Clin. Psychiatry 51(4): 164-6.
4. Brown, R. P. and Kocsis, J. H. (1984) 'Sudden Death and Antipsychotic Drugs'. Hosp. Community Psychiatry 35: 486-91.
5. Donlon, P. T., Hopkin, J. and Tupin, J. P. (1979) 'Overview: Efficacy and Safety of the Rapid Neuroleptization Method with Injectable Haloperidol'. American Journal of Psychiatry 136(3): 273-8.
6. Endicott, J., Spitzer, J. L. and Fleiss, J. (1976) 'The Global Assessment Scale: a Procedure for Measuring Overall Severity of Psychiatric Disturbance'. Arch. Gen. Psychiatry 33: 766-71.
7. Faraone, S. V., Green, A. I., Brown, W., Yin, P. and Tsuang, M. T. (1989) 'Neuroleptic Dose Reduction in Persistently Psychotic Patients'. Hosp. Community Psychiatry 40(11): 1193-5.
8. Fleishman, M. (1994) 'High Dose Neuroleptics (Letter)'. Hosp. Community Psychiatry 45(7): 721-2.
9. Gagne, M.-A., Cormier, H., Leblanc, G., Levesque, D. and Di Paolo, T. (1993) 'Study of the Clinical Utility of Radioreceptor Assay in Outpatients with Schizophrenia Receiving High Doses of Neuroleptics'. Canadian Journal of Psychiatry 38: 534-40.
10. Hirsch, S. R. and Barnes, T. R. E. (1994) 'Clinical Use of High-Dose Neuroleptics'. British Journal of Psychiatry 164: 94-6.
11. Honigfeld, G. and Klett, C. J. (1965) 'The Nurses Observation Scale for Inpatient Evaluation: a New Scale for Measuring Improvement in Chronic Schizophrenia'. J. Clin. Psychol. 21: 65-71.
12. Krakowski, M. I., Kunz, M., Czobor, P. and Volavka, J. (1993) 'Long-Term High-Dose Neuroleptic Treatment: Who Gets It and Why?' Hosp. Community Psychiatry 44(7): 640-4.
13. Lader, M. (1994) 'Benzodiazepines: a Risk-Benefit Profile'. CNS Drugs 1(5): 377-87.
14. Leblanc, G., Cormier, H., Gagne, M.-A. and Vaillancourt, S. (1994) 'Effects of Neuroleptic Reduction in Schizophrenic Outpatients Receiving High Doses'. Canadian Journal of Psychiatry 39: 223-9.
15. Lingjaerde, O. (1987) 'UKU Side-effect Rating Scale. A New Comprehensive Rating Scale for Psychotropic Drugs and a Cross-sectional Study of Side-effects in Neuroleptic Treated Patients'. Acta Psychiatr. Scand. 76 (suppl. 334): 83-100.
16. Little, K. Y., Gay, T. L. and Vore, M. (1989) 'Predictors of Response to High-dose Antipsychotics in Chronic Schizophrenics'. Psychiatry Res. 30(1): 1-9.
17. McEvoy, J. P., Hogarty, G. E. and Steingard, S. (1991) 'Optimal Dose of Neuroleptic in Acute Schizophrenia'. Arch. Gen. Psychiatry 48: 739-45.
18. Overall, J. E. and Gorham, D. R. (1962) 'The Brief Psychiatric Rating Scale'. Psychol. Rep. 10: 799-812.
19. Peralta, V., Cuesta, M. J., Caro, F. and Martinez-Larrea, A. (1994) 'Neuroleptic Dose and Schizophrenic Symptoms: a Survey of Prescribing Practices'. Acta Psychiatr. Scand. 90: 354-7.
20. Prien, R. F., Levine, J. and Cole, J. O. (1970) 'Indications for High Dose Chlorpromazine Therapy in Chronic Schizophrenia'. Dis. Nerv. Syst. 31(11): 739-45.
21. Remington, G., Pollock, B., Voineskos, G., Reed, K. and Coulter, K. (1993) 'Acutely Psychotic Patients Receiving High-Dose Haloperidol Therapy'. J. Clin. Psychopharmacol. 13: 41-5.
22. Rifkin, A., Doddi, S., Karajgi, B., Borenstein, M. and Wachspress, M. (1991) 'Dosage of Haloperidol for Schizophrenia'. Arch. Gen. Psychiatry 48: 166-70.
23. Sprague, R. L. and Kalachnik, J. E. (1991) 'Reliability, Validity and a Total Score Cutoff for the Dyskinesia Identification System: Condensed User Scale (DISCUS) with Mentally Ill and Mentally Retarded Populations'. Psychopharmacol. Bull. 27(1): 51-8.
24. Thompson, C. (1994) 'The Use of High-Dose Antipsychotic Medication'. British Journal of Psychiatry 164: 448-58.
25. Van Putten, T., Marder, S. R., Mintz, J. and Poland, R. E. (1992) 'Haloperidol Plasma Levels and Clinical Response: a Therapeutic Window Relationship'. American Journal of Psychiatry 149(4): 500-5.
26. Van Putten, T., Marshall, B. D., Liberman, R. et al. (1993) 'Systematic Dose Reduction in Treatment-Resistant Schizophrenic Patients'. Psychopharmacol. Bulletin 29: 315-20.
27. Vaughn, C. E. and Leff, J. P. (1976) 'The Influence of Family and Social Factors on the Course of Psychiatric Illness'. British Journal of Psychiatry 129: 125-37.
28. Volavka, J., Cooper, T., Czobor, P. et al. (1992) 'Haloperidol Blood Levels and Clinical Effects'. Arch. Gen. Psychiatry 49: 354-61.
29. Wistedt, B., Rasmussen, A., Pedersen, L. et al. (1990) 'The Development of an Observer-Scale for Measuring Social Dysfunction and Aggression'. Pharmacopsychiatry 23: 249-52.
30. Zito, J. M., Craig, T. J., Wanderling, J. and Siegel, C. (1987) 'Pharmaco-Epidemiology in 136 Hospitalized Schizophrenic Patients'. American Journal of Psychiatry 144(6): 778-82.